About US
Contact us
-
FDA panel draws blood in Xarelto's bid for new useLesson from FDA's panel meeting on Xarelto: Beware of "missingness." After a spirited debate over some missing study data, the advisory committee refused to back a big new use for the blood thinner. B2012/5/25
-
Sanofi eyes Chinese cancer market with early drug trialSanofi($SNY) CEO Chris Viehbacher is betting that an experimental liver cancer drug could make big inroads in China. The company is going ahead with the first human trials of the drug next year.2012/5/25
-
Study: Docs barring pharma reps has unexpected side effectsPharma reps, take heart. A new study finds that barring you from doctors' offices has some deleterious effects. It cut back on adoption of a brand-new, first-in-class diabetes drug--Merck's ($MRK)2012/5/24
-
Merck CEO assures shareholders there is life after death of Singulair patentWith its $5.5 billion seller Singulair going off patent in two months, things will be a little dicey for the next couple of years at Merck ($MRK). But CEO Kenneth Frazier assures shareholders that2012/5/24
-
Bayer's Nexavar falters in another lung cancer trialOnce again, Bayer sent Nexavar out to conquer new lung cancer territory. And once again, the disease defended itself too well. The company and its Nexavar partner, Onyx Pharmaceuticals ($ONXX), said t2012/5/23
-
Fired Pfizer rep sues, claiming pregnancy-related discriminationA Pfizer ($PFE) sales rep has sued the company, saying she was fired because of her pregnancy, Pharmalot reports. Marie Hand, who repped for King Pharmaceuticals when Pfizer bought the company, says s2012/5/23
-
FDA in line for new foreign-inspection powersTheSenate is preparing to reauthorize the FDA's all-important user-fee funding. But that's not all the latest Prescription Drug User Fee Act would do. The FDA would get new powers to police imported d2012/5/22
-
How does pharma's CEO pay rank?We know how pharma CEO pay stacked up within the industry. But how did pharma's 2011 compensation packages compare with those in other industries? The Wall Street Journal answers that question with it2012/5/22
-
Even some domestic firms rail at India's price control planIndia's plan to again put price controls on the majority of the drugs in the country has become a flash point forcompanies there as well as Western drugmakers. The proposal is being debated now an2012/5/21
-
Johnson & Johnson recalls a lot of ImodiumJohnson & Johnson's ($JNJ) McNeil Consumer Healthcare, which has gotten accustomed to recalling products in large quantities, is retrieving a lot of Imodium--nearly 54,000 packages. There is no he2012/5/21